Similarly, downregulation of miR-145 corresponded to higher SMAD3 expression and EMT process induction in nasopharyngeal cancer cells [49] or inhibited TGFβR2 and SMAD3 in bladder cancer [50]. This evidence concerns the gene TGFBR2 and urinary bladder carcinoma.